MEDI4736 Combinations in Metastatic Renal Cell Carcinoma

Clinical trial NCT02819596 · COMPLETED

Trial details

NCT number: NCT02819596
Sponsor: Queen Mary University of London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Clear Cell Carcinoma Renal Papillary Cell Carcinoma

Start date: 2016-05-03
Primary completion: 2024-07-17
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.